| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |